Cachexia: The Devastating Wasting Disorder Linked to Chronic Illnesses

Cachexia is a severe wasting disorder that causes extreme weight loss and muscle breakdown. It often appears in the late stages of serious illnesses like cancer, COPD, and heart failure. The condition weakens the body, leaving patients more vulnerable to infections and complications. The term cachexia comes from the Greek words kakos (bad) and hexis (condition). It describes a state where the body loses muscle and fat, even when food intake remains stable. Unlike simple weight loss, cachexia is involuntary—driven by reduced appetite and a faster metabolism that breaks down muscle for energy.

Cachexia commonly affects people with advanced illnesses. Up to 80% of those with late-stage cancer may develop it, along with 50% of patients with COPD or congestive heart failure. It also appears in HIV/AIDS, kidney disease, and other chronic conditions. Doctors divide cachexia into three stages: precachexia, cachexia, and refractory cachexia. Symptoms include rapid weight loss, muscle weakness, fatigue, and a sharp drop in appetite. Researchers believe the body triggers cachexia to prioritise energy for the brain when nutritional reserves run low. There is no cure for cachexia, and treatments focus on easing symptoms and improving quality of life. Patients receive nutritional support, appetite stimulants, and sometimes anti-inflammatory drugs. However, the condition often worsens as the underlying disease progresses.

Cachexia remains a major challenge in managing chronic illnesses. Without a direct cure, medical care aims to slow its progression and reduce suffering. The condition significantly raises the risk of death, making early symptom management critical for affected patients.